查看購物車
  • Simplified Chinese
  • Japanese
  • Korean
青光眼手術設備市場(2025年):全球市場分析(2024年～2030年)
市場調查報告書
商品編碼
1791925

青光眼手術設備市場(2025年):全球市場分析(2024年～2030年)

2025 Glaucoma Surgical Device Market Report: Global Analysis for 2024 to 2030
出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

最新資訊

"青光眼手術器械市場報告 (2025)" 介紹了每個產品類別過去六年的銷售歷史記錄，並分析了影響這些趨勢的臨床和商業事件，為未來預測提供了關鍵背景。

新報告重點介紹了一系列針對晚期青光眼的創新結膜下器械，包括 Avis 的超薄濾過板、Myra Vision 的術後可調分流器以及 Ciliatech 的葡萄膜鞏膜植入物。此外，報告還重點介紹了 Iantrek 和 iStar Medical 的新型膽道上器械，為外科醫生提供了引流部位選擇。

下一代青光眼雷射器，例如愛爾康的 Voyager DSLT、ViaLase 的 ViaLuxe 和博士倫的 Elios，預計將推動強勁的收入成長。本報告提供了這些系統的詳細資訊以及雷射產業的最新預測。

我們也提供了擴展的區域報銷和監管分析，概述了審批途徑、政策變化和報銷挑戰。

"青光眼手術器械市場報告（2025）" 提供了全球青光眼手術器械市場的數據驅動分析，全面涵蓋了現有技術、創新管道、競爭定位和區域成長機會。

我們研究了全球青光眼的盛行率和治療趨勢。我們也詳細介紹了所有已商業化的器械，包括微型支架、結膜下分流器、鼻道手術器械和導管分流器，並評估了有望改善治療效果並推動未來應用的在研產品線。

市場細分預測了截至 2030 年的市場需求（以數量和金額計算），並按器械類別、手術類型和地區進行了詳細細分。競爭分析包括市場佔有率預測、產品推出計劃以及 29 家領先和新興公司的詳細概況，重點介紹他們的產品、策略定位以及在這一快速發展領域的前景。

目錄

2025 年青光眼手術器械市場概況提供了最全面、最具策略意義的全球市場概覽。它涵蓋了五個主要器械類別的現有技術和新興技術：微型支架、結膜下分流器、鼻道手術器械、導管分流器和青光眼雷射。它還提供了詳細的五年市場估計和收入預測，以及競爭對手的市場佔有率分析。

本報告也包含以下內容：

  • 按國家/地區和設備類型細分的全球市場預測
  • 深入探討手術趨勢、手術方式及醫師採用模式
  • 分析美國、歐洲、亞洲和其他主要地區的報銷趨勢
  • 詳細介紹了約 30 家領先和新興設備製造商的公司簡介
  • 新增了關於持續給藥設備、雷射技術創新以及手術在青光眼治療中的作用變化的章節
  • 按房水引流部位對手術器械進行細分，反映了外科醫師對治療方案的實際分類方式

本報告以研究數據和行業領先的市場模型為支撐，旨在成為行業領導者、投資者和策略家了解青光眼治療設備市場現狀和未來方向的重要資源。

簡介目錄

What's New:

The "2025 Glaucoma Surgical Device Market Report" includes a new six-year sales history for each product category, along with analysis of the clinical and commercial events that shaped those trends to provide crucial context for future projections.

The new report spotlights a wave of innovative subconjunctival devices targeting advanced glaucoma, including Avisi's ultrathin filtration plate, Myra Vision's post-op adjustable shunt, and Ciliatech's uveoscleral implant. It also highlights new supraciliary devices from Iantrek and iStar Medical that offer surgeons additional drainage site options.

Next-generation glaucoma lasers-such as Alcon's Voyager DSLT, ViaLase's ViaLuxe, and Bausch + Lomb's Elios-are expected to drive strong revenue growth. The report details these systems and provides updated forecasts for the laser segment.

Expanded reimbursement and regulatory analysis is now provided by region, outlining approval pathways, policy shifts, and reimbursement challenges.

The "2025 Glaucoma Surgical Device Market Report" provides a data-driven analysis of the global market for glaucoma surgical devices, offering comprehensive coverage of current technologies, innovation pipelines, competitive positioning, and growth opportunities by region.

The report examines global glaucoma prevalence and treatment trends. It details the full spectrum of commercialized devices-including microstents, subconjunctival shunts, canal surgery devices, and tube shunts-and evaluates the pipeline of investigational products that are poised to improve outcomes and drive future adoption.

Market demand is forecast in both units and dollars through 2030, with detailed segmentation by device category, procedure type, and region. Competitive analysis includes market share estimates, plans for product adoption, and detailed profiles of 29 leading and emerging companies, highlighting their products, strategic positioning, and outlook in this rapidly evolving segment.

Contents:

The "2025 Glaucoma Surgical Device Market Report" offers the most comprehensive and strategic overview of the global market to date. It covers current and emerging technologies across five key device categories: microstents, subconjunctival shunts, canal surgery devices, tube shunts, and glaucoma lasers-with detailed five-year forecasts, unit and revenue estimates, and competitor market share analysis.

The report also features:

  • A global market forecast segmented by country/region and device type
  • Deep dives into surgical trends, procedure settings, and physician adoption patterns
  • Analysis of the reimbursement landscape across the US, Europe, Asia, and other major regions
  • In-depth company profiles for nearly 30 leading and emerging device manufacturers
  • New sections on sustained drug-delivery devices, laser innovation, and the changing role of surgery in glaucoma care
  • Updated classification of surgical devices by aqueous drainage site, reflecting how surgeons categorize treatment options in practice

Backed by survey data and industry-leading market modeling, this report is designed to be an essential resource for industry leaders, investors, and strategists seeking to understand where the glaucoma device market stands-and where it's headed next.